Skip to main content
. 2019 Nov 27;9(3):307–320. doi: 10.1002/cpdd.749

Figure 2.

Figure 2

Least squares mean difference of QTcF (milliseconds) for 400 mg/daya sertraline versus placebo and 400 mg moxifloxacin versus placebo at each time point after dosing on day 14 for the primary ECG analysis population. BID, twice daily; ECG, electrocardiogram; QTcF, QT corrected for heart rate using Fridericia formula. aDosing was 200 mg BID; postdose blood draws for pharmacokinetic analyses were completed after the morning 200‐mg dose, and no further doses were administered.